Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ARID1A |
Variant | A35Gfs*76 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ARID1A A35Gfs*76 indicates a shift in the reading frame starting at amino acid 35 and terminating 76 residues downstream causing a premature truncation of the 2285 amino acid Arid1a protein (UniProt.org). A35Gfs*76 has not been characterized however, due to the effects of other truncation mutations downstream of A35 (PMID: 26069190, PMID: 29736026), is predicted to lead to a loss of Arid1a protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ARID1A mutant ARID1A inact mut ARID1A A35Gfs*76 |
Transcript | NM_006015.6 |
gDNA | chr1:g.26696506dupG |
cDNA | c.103dupG |
Protein | p.A35Gfs*76 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_006015.6 | chr1:g.26696506dupG | c.103dupG | p.A35Gfs*76 | RefSeq | GRCh38/hg38 |
NM_139135.3 | chr1:g.26696506dupG | c.103dupG | p.A35Gfs*76 | RefSeq | GRCh38/hg38 |
NM_006015.5 | chr1:g.26696506dupG | c.103dupG | p.A35Gfs*76 | RefSeq | GRCh38/hg38 |
NM_139135.4 | chr1:g.26696506dupG | c.103dupG | p.A35Gfs*76 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
ARID1A A35Gfs*76 | cholangiocarcinoma | no benefit | Olaparib | Preclinical - Patient cell culture | Actionable | In a preclinical study, a cholangiocarcinoma patient-derived xenograft (PDX) cell line harboring ARID1A A35Gfs*76 was insensitive to Lynparza (olaparib) in culture (PMID: 36374558). | 36374558 |
ARID1A A35Gfs*76 | cholangiocarcinoma | no benefit | Pamiparib | Preclinical - Patient cell culture | Actionable | In a preclinical study, a cholangiocarcinoma patient-derived xenograft (PDX) cell line harboring ARID1A A35Gfs*76 was insensitive to Pamiparib (BGB-290) in culture (PMID: 36374558). | 36374558 |
ARID1A A35Gfs*76 | cholangiocarcinoma | no benefit | Niraparib | Preclinical - Patient cell culture | Actionable | In a preclinical study, a cholangiocarcinoma patient-derived xenograft (PDX) cell line harboring ARID1A A35Gfs*76 was insensitive to Zejula (niraparib) in culture (PMID: 36374558). | 36374558 |